                               SEQUENCE LISTING

<110> IMMUNOMEDICS, INC.

<120> RADIOSENSITIVITY OF FLUOROPHORES AND USE OF RADIOPROTECTIVE 
      AGENTS FOR DUAL-MODALITY IMAGING

<130> IMM354WO1

<140>
<141>

<150> 62/101,508
<151> 2015-01-09

<160> 30    

<170> PatentIn version 3.5

<210> 1
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> DOTA-Phe 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Lys(HSG)

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Lys(HSG)-NH2

<400> 1
Phe Lys Tyr Lys 
1               


<210> 2
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Ac-Lys(DTPA)

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Lys(DTPA)

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Lys side chain modified with thiosemicarbazonylglyoxylcysteine 

<220>
<223> C-term NH2

<400> 2
Lys Tyr Lys Lys 
1                  


<210> 3
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> NODA-MPAA-PEG4-Gln

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Met-NH2

<400> 3
Gln Trp Ala Val Gly His Leu Met 
1               5               


<210> 4
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> NOTA-D-Ala 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> D-Lys(HSG)

<220>
<221> MOD_RES
<222> (3)..(3)
<223> D-Tyr 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> D-Lys(HSG)-NH2

<400> 4
Ala Lys Tyr Lys 
1               


<210> 5
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> NODA-MPAA-beta-Ala

<220>
<221> MOD_RES
<222> (2)..(2)
<223> beta-Ala 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> D-Phe 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Sta 

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Leu-NH2

<400> 5
Ala Ala Phe Gln Trp Ala Val Gly His Xaa Leu 
1               5                   10      


<210> 6
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> DTPA-Gln

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Lys(HSG)

<220>
<221> MOD_RES
<222> (4)..(4)
<223> D-Tyr 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Lys(HSG)-NH2

<400> 6
Gln Ala Lys Tyr Lys 
1               5   


<210> 7
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> NOTA-benzyl-ITC-D-Ala 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> D-Lys(HSG)

<220>
<221> MOD_RES
<222> (3)..(3)
<223> D-Tyr 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> D-Lys(HSG)-NH2

<400> 7
Ala Lys Tyr Lys 
1               


<210> 8
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> D-Ala 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> D-Lys(HSG)

<220>
<221> MOD_RES
<222> (3)..(3)
<223> D-Tyr 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> D-Lys(HSG)-NH2

<400> 8
Ala Lys Tyr Lys 
1               


<210> 9
<211> 44
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 9
Ser His Ile Gln Ile Pro Pro Gly Leu Thr Glu Leu Leu Gln Gly Tyr 
1               5                   10                  15      


Thr Val Glu Val Leu Arg Gln Gln Pro Pro Asp Leu Val Glu Phe Ala 
            20                  25                  30          


Val Glu Tyr Phe Thr Arg Leu Arg Glu Ala Arg Ala 
        35                  40                  


<210> 10
<211> 45
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 10
Cys Gly His Ile Gln Ile Pro Pro Gly Leu Thr Glu Leu Leu Gln Gly 
1               5                   10                  15      


Tyr Thr Val Glu Val Leu Arg Gln Gln Pro Pro Asp Leu Val Glu Phe 
            20                  25                  30          


Ala Val Glu Tyr Phe Thr Arg Leu Arg Glu Ala Arg Ala 
        35                  40                  45  


<210> 11
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Gln Ile Glu Tyr Leu Ala Lys Gln Ile Val Asp Asn Ala Ile Gln Gln 
1               5                   10                  15      


Ala 
    


<210> 12
<211> 21
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Cys Gly Gln Ile Glu Tyr Leu Ala Lys Gln Ile Val Asp Asn Ala Ile 
1               5                   10                  15      


Gln Gln Ala Gly Cys 
            20      


<210> 13
<211> 55
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide

<400> 13
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser His Ile Gln Ile 
1               5                   10                  15      


Pro Pro Gly Leu Thr Glu Leu Leu Gln Gly Tyr Thr Val Glu Val Leu 
            20                  25                  30          


Arg Gln Gln Pro Pro Asp Leu Val Glu Phe Ala Val Glu Tyr Phe Thr 
        35                  40                  45              


Arg Leu Arg Glu Ala Arg Ala 
    50                  55  


<210> 14
<211> 29
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Gly Ser Gly Gly Gly Gly Ser Gly Gly Gly Gly Ser Gln Ile Glu Tyr 
1               5                   10                  15      


Leu Ala Lys Gln Ile Val Asp Asn Ala Ile Gln Gln Ala 
            20                  25                  


<210> 15
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> NOTA-Ga-D-Ala 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> D-Lys(HSG)
 
<220>
<221> MOD_RES
<222> (3)..(3)
<223> D-Tyr 
 
<220>
<221> MOD_RES
<222> (4)..(4)
<223> D-Lys(HSG)-NH2
 
<400> 15
Ala Lys Tyr Lys 
1               


<210> 16
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> NOTA-D-Asp 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> D-Lys(HSG)
 
<220>
<221> MOD_RES
<222> (3)..(3)
<223> D-Tyr 
 
<220>
<221> MOD_RES
<222> (4)..(4)
<223> D-Lys(HSG)-NH2
 
<400> 16
Asp Lys Tyr Lys 
1               


<210> 17
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> C-NETA-succinyl-D-Lys(HSG)

<220>
<221> MOD_RES
<222> (2)..(2)
<223> D-Tyr 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> D-Lys(HSG)-NH2

<400> 17
Lys Tyr Lys 
1           


<210> 18
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Al(NOTA)-D-Ala 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> D-Lys(HSG)
 
<220>
<221> MOD_RES
<222> (3)..(3)
<223> D-Tyr 
 
<220>
<221> MOD_RES
<222> (4)..(4)
<223> D-Lys(HSG)-NH2
 
<400> 18
Ala Lys Tyr Lys 
1               


<210> 19
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> NOTA-NH-(CH2)7CO-Gln 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Met-NH2

<400> 19
Gln Trp Val Trp Ala Val Gly His Leu Met 
1               5                   10  


<210> 20
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> NOTA-D-Phe 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> D-Trp 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Throl

<400> 20
Phe Cys Phe Trp Lys Thr Cys Thr 
1               5               


<210> 21
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> DOTA-D-Tyr 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> D-Lys(HSG)

<220>
<221> MOD_RES
<222> (3)..(3)
<223> D-Glu 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> D-Lys(HSG)-NH2

<400> 21
Tyr Lys Glu Lys 
1               


<210> 22
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> NODA-MPAA-D-Phe 

<220>
<221> MOD_RES
<222> (4)..(4)
<223> D-Trp 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Throl

<400> 22
Phe Cys Phe Trp Lys Thr Cys Thr 
1               5               


<210> 23
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> NODA-MPAA-(PEG)3-Gln 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Met-NH2

<400> 23
Gln Trp Ala Val Gly His Leu Met 
1               5               


<210> 24
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1) 
<223> NODA-HA-D-Ala

<220>
<221> MOD_RES
<222> (2)..(2) 
<223> D-Lys(HSG)

<220>
<221> MOD_RES
<222> (3)..(3) 
<223> D-Tyr 

<220>
<221> MOD_RES
<222> (4)..(4) 
<223> D-Lys(HSG)-NH2

<400> 24
Ala Lys Tyr Lys 
1               


<210> 25
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1) 
<223> NODA-MPAA-D-Lys(HSG)

<220>
<221> MOD_RES
<222> (2)..(2) 
<223> D-Tyr 

<220>
<221> MOD_RES
<222> (3)..(3) 
<223> D-Lys(HSG)-NH2

<400> 25
Lys Tyr Lys 
1           


<210> 26
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1) 
<223> NODA-EPA-succinyl-D-Lys(HSG)

<220>
<221> MOD_RES
<222> (2)..(2) 
<223> D-Tyr 

<220>
<221> MOD_RES
<222> (3)..(3) 
<223> D-Lys(HSG)-NH2

<400> 26
Lys Tyr Lys 
1           


<210> 27
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1) 
<223> NODA-EBA-D-Glu

<220>
<221> MOD_RES
<222> (2)..(2) 
<223> D-Lys(HSG) 

<220>
<221> MOD_RES
<222> (3)..(3) 
<223> D-Tyr 

<220>
<221> MOD_RES
<222> (4)..(4) 
<223> D-Lys(HSG)-NH2

<400> 27
Glu Lys Tyr Lys 
1               


<210> 28
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1) 
<223> NODA-MBA-D-Glu

<220>
<221> MOD_RES
<222> (2)..(2) 
<223> D-Lys(HSG) 

<220>
<221> MOD_RES
<222> (3)..(3) 
<223> D-Tyr 

<220>
<221> MOD_RES
<222> (4)..(4) 
<223> D-Lys(HSG)-NH2

<400> 28
Glu Lys Tyr Lys 
1               


<210> 29
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1) 
<223> D-Lys(HSG)

<220>
<221> MOD_RES
<222> (2)..(2) 
<223> D-Tyr 

<220>
<221> MOD_RES
<222> (3)..(3) 
<223> D-Lys(HSG)-NH2

<400> 29
Lys Tyr Lys 
1           


<210> 30
<211> 3
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1) 
<223> D-Lys(HSG)

<220>
<221> MOD_RES
<222> (2)..(2) 
<223> D-Tyr 

<220>
<221> MOD_RES
<222> (3)..(3) 
<223> D-Lys(HSG)-NH2

<400> 30
Lys Tyr Lys 
1           


